Advertisement

Index by author

May 01, 2002; Volume 30,Issue 5

  1. Satoh, Tetsuo

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  2. Savolainen, Jouko

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

  3. Sharma, Vyas

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  4. Shimada, Tsutomu

    1. Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

  5. Shindo, Masaki

    1. Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

  6. Shinozaki, Yutaka

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

  7. Snel, C. A. W.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  8. Soukhova, Nadia V.

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  9. Steimel, Dorothy T.

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  10. Su, Ting

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
« Previous (Pages : 4 5 6 7 8 9 10 11 ... 11) Next »
Back to top

In this issue

Advertisement